Proposed coronavirus vaccine price capped at Rs 225 per dose
Pune : Pune-based Serum Institute, the world's largest vaccine manufacturer by volume, has capped the selling price of $3 per dose for the proposed coronavirus vaccine. The price has been capped for India and other low/middle income countries (LMICs).
The Bill & Melinda Gates Foundation will provide an at-risk funding of $150 million to Gavi (Global Alliance for Vaccines and Immunisation), which will be used to support Serum to manufacture potential vaccine candidates, including the ones from UK firm AstraZeneca, and US biotech company Novavax.
The capped price of proposed vaccine will be for 92 countries under the Covax alliance — co-led by Gavi, Coalition for Epidemic Preparedness Innovations (CEPI) and World Health Organization (WHO), formed to accelerate development of Covid-19 vaccines and ensure their rapid and equitable access.